SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-118310
Filing Date
2016-05-05
Accepted
2016-05-05 16:20:36
Documents
3
Period of Report
2016-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-10150_18k.htm 8-K 24398
2 EX-99.1 a16-10150_1ex99d1.htm EX-99.1 88558
3 GRAPHIC g101501mmi001.gif GRAPHIC 4663
  Complete submission text file 0001104659-16-118310.txt   120674
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 161624088
SIC: 2834 Pharmaceutical Preparations